Evidence map›Paper›PMID 24061274›Full record

Trial reportThe Pediatric infectious disease journal2014

Characteristics of vaccine failures in a randomized placebo-controlled trial of inactivated influenza vaccine in children.

Sophia Ng, Michael Y Ni, Vicky Jing Fang, Dennis Kai Ming Ip, Kwok-Hung Chan, Gabriel Matthew Leung, Joseph Sriyal Malik Peiris, Benjamin John Cowling

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Pediatric infectious disease journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Progress towards the development of aExpert review of vaccines · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Vaccine epidemiology: A review.Journal of family medicine and primary care
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Sophia NgFrom the *School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China; †Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ; ‡Department of Microbiology, Li Ka Shing Faculty of Medicine; and §Centre for Influenza Research, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
Michael Y Ni
Vicky Jing Fang
Dennis Kai Ming Ip
Kwok-Hung Chan
Gabriel Matthew Leung
Joseph Sriyal Malik Peiris
Benjamin John Cowling
University of Hong Kong · HKLi Ka Shing Foundation · CN

Funding

Understanding and controlling antibiotic resistanceU54GM088558 · NIGMS · HARVARD SCHOOL OF PUBLIC HEALTH · PI HANAGE, WILLIAM · 2009 to 2018
$26.4M
NIGMS NIH HHS U54 GM088558
6 · The paper itself

Abstract

backgroundInfections occurring among vaccinated persons (vaccine failures) are known to occur in vaccines with imperfect efficacy. Failures among vaccinated children who were infected with vaccine-matched influenza B virus strain have not been adequately characterized.

methodsTaking advantage of a randomized controlled trial of trivalent seasonal influenza vaccine (TIV), the viral shedding and clinical symptoms associated with reverse transcriptase polymerase chain reaction-confirmed influenza B infection and serum hemaggluttination inhibiting antibody response to vaccine were compared between children 6 and 17 years receiving TIV and placebo.

resultsVaccine failures were observed to show lower antibody response to TIV compared with other vaccine recipients. We did not find any evidence that vaccination reduced the severity or duration of clinical symptoms of reverse transcriptase polymerase chain reaction-confirmed vaccine-matched influenza B infections. Vaccination was not observed to alter viral load or shedding duration.

conclusionsTIV was not observed to ameliorate clinical symptoms or viral shedding among vaccine failures compared with infected placebo recipients. Lower antibody response might have explained vaccine failure and also lack of effect in reducing clinical symptoms and viral shedding upon infection. Our results are based on a randomized controlled trial of split virus inactivated vaccine and may not be applicable to other vaccine types. Further studies in vaccine failure among children will be important in future vaccine development.

Indexed as

AdolescentAntibodies, ViralChildDouble-Blind MethodHumansInfluenza B virusInfluenza, HumanInfluenza VaccinesPlacebosVaccines, InactivatedVirus SheddingAntibodies, ViralInfluenza VaccinesPlacebosVaccines, Inactivatedvaxigrip

Identifiers

PMID24061274
PMCPMC3947204
OpenAlexW2023631825

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.